IL-2 Antikörper (FITC)
(1 reference)Kurzübersicht für IL-2 Antikörper (FITC) (ABIN2474968)
Target
Alle IL-2 (IL2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Cynomolgus
-
Produktmerkmale
- Purified IgG
-
Isotyp
- IgG2a
-
-
anti-Interleukin 2 (IL2) (AA 21-153) antibody
IL2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 2 (IL2) (AA 21-153) antibodyIL2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C3 unconjugated
anti-Interleukin 2 (IL2) (AA 10-169) antibodyIL2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 2 (IL2) (AA 21-153) antibodyIL2 Reaktivität: Human WB Wirt: Maus Monoclonal C5 unconjugated
anti-Interleukin 2 (IL2) antibodyIL2 Reaktivität: Human WB, ELISA, IP, FACS, ICC Wirt: Maus Monoclonal 35C3 unconjugated
anti-Interleukin 2 (IL2) antibodyIL2 Reaktivität: Human WB, ELISA, FACS Wirt: Kaninchen Monoclonal unconjugated
anti-Interleukin 2 (IL2) antibody (APC)IL2 Reaktivität: Human ICFC Wirt: Maus Monoclonal 35C3 APC
anti-Interleukin 2 (IL2) antibody (PE)IL2 Reaktivität: Human FACS Wirt: Maus Monoclonal 35C3 PE
anti-Interleukin 2 (IL2) (AA 21-155) antibodyIL2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Interleukin 2 (IL2) (AA 10-169) antibodyIL2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Maus Monoclonal C12 unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.1 mg/mL
-
-
-
: "Semiallogenic fusions of MSI(+) tumor cells and activated B cells induce MSI-specific T cell responses." in: BMC cancer, Vol. 11, pp. 410, (2011) (PubMed).
-
: "Semiallogenic fusions of MSI(+) tumor cells and activated B cells induce MSI-specific T cell responses." in: BMC cancer, Vol. 11, pp. 410, (2011) (PubMed).
-
- IL-2 (IL2) (Interleukin 2 (IL2))
-
Andere Bezeichnung
- IL-2
-
Gen-ID
- 3558
-
UniProt
- P60568
-
Pathways
- JAK-STAT Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Target
-
